SCHEMBL8088906

SCHEMBL8088906

C=CCNC(=O)N1CCC1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
TGM2 P21980 1/20 0.42
MAPT P10636 2/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HTT P42858 1/20 0.37
EPHX2 P34913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22545922 0.94 TGM2 (0.45) KMT2ATGM2MAPTTSHRSMN1; SMN2
SCHEMBL11501378 0.94 TGM2 (0.45) KMT2ATGM2MAPTTSHRSMN1; SMN2
SCHEMBL7750555 0.91
SCHEMBL2187966 0.82 KMT2A (0.48) KMT2AMAPTTSHRSMN1; SMN2MEN1
SCHEMBL8448473 0.82 KMT2A (0.40) KMT2AMAPTTSHRSMN1; SMN2RAB9A
SCHEMBL7456594 0.82 MAPT (0.64) KMT2AMAPTSMN1; SMN2RAB9AMEN1
SCHEMBL1783979 0.82 KMT2A (0.44) KMT2AMAPTTSHRSMN1; SMN2KDM4E
SCHEMBL7536185 0.81 KMT2A (0.42) KMT2AMAPTTSHRSMN1; SMN2RAB9A
SCHEMBL27733678 0.75 KMT2A (0.43) KMT2ATGM2SMN1; SMN2RAB9AMEN1
SCHEMBL2993373 0.75 KMT2A (0.44) KMT2AMAPTTSHRSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049672-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 2000-11-08 EP claimed
WO-1999037612-A1 AZETIDINECARBOXAMIDE DERIVATIVES FOR TREATING CNS DISORDERS VERNALIS RESEARCH LIMITED (GB) 1999-07-29 WO claimed